Group photo (IMAGE)

The University of Hong Kong

Group photo

Caption

The study led by Professor Shirley Li Xue (second right) finds that a combination of policies and service measures could enhance the value and affordability of esketamine nasal spray, a novel rapid-acting treatment for adults with treatment-resistant depression (TRD) in Hong Kong.

Credit

The University of Hong Kong

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.